Glorikian Publications
Intellectual property considerations for molecular diagnostic development with emphasis on…
MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market How…
The MoneyBall solution to the healthcare crisis Many recent articles…
This is why pre-design research is essential for the IVD…
Learning from failure: What Theranos, Interleukin Genetics, & Courtagen can…
Do You Have the Data to Benefit from a Post-Keytruda…
MDBR Interviews Harry Glorikian About the Growing Significance of In…
Q&A: Healthcare Industry Expert Harry Glorikian Discusses His New IVD…
Remote Patient Care: The Future Of Remote Monitoring And Diagnostics…
Harry Glorikian discusses the field of In Vitro diagnostics Industry…
Commercializing Novel IVDs: A Comprehensive Manual for Success The process…
Leadership Series Featuring Harry Glorikian, Senior Executive, Board Director, Consultant,…
Gene Editing Will Change Everything – Just Not All At…
Early Detection: The Real Way to Beat Cancer Several new…
Precision medicine: New opportunity in the age of conscious medicine…
Genomics: gearing up for the laboratory of the future A…
Sequencing Trends Worth Watching Sequencing Trends worth watching – Authors:…
POCT key to widespread access to healthcare Decentralization of healthcare…
Next Generation Sequencing Market Remains on Upward Trajectory Two key…
Cellular Biology Market Shows Resilience Segment Encompasses a Plethora of…